BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15061261)

  • 1. P-glycoprotein expression is associated with FDG uptake and cell differentiation in patients with untreated lung cancer.
    Higashi K; Ueda Y; Ikeda R; Kodama Y; Guo J; Matsunari I; Oguchi M; Tonami H; Katsuda S; Yamamoto I
    Nucl Med Commun; 2004 Jan; 25(1):19-27. PubMed ID: 15061261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of Glut-1 glucose transporter expression with.
    Higashi K; Ueda Y; Sakurai A; Wang XM; Xu L; Murakami M; Seki H; Oguchi M; Taki S; Nambu Y; Tonami H; Katsuda S; Yamamoto I
    Eur J Nucl Med; 2000 Dec; 27(12):1778-85. PubMed ID: 11189940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of [18F]fluorodeoxyglucose uptake with glucose transporter-1 expression and proliferation rate in human glioma and non-small-cell lung cancer.
    Chung JK; Lee YJ; Kim SK; Jeong JM; Lee DS; Lee MC
    Nucl Med Commun; 2004 Jan; 25(1):11-7. PubMed ID: 15061260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDG PET in the evaluation of the aggressiveness of pulmonary adenocarcinoma: correlation with histopathological features.
    Higashi K; Ueda Y; Ayabe K; Sakurai A; Seki H; Nambu Y; Oguchi M; Shikata H; Taki S; Tonami H; Katsuda S; Yamamoto I
    Nucl Med Commun; 2000 Aug; 21(8):707-14. PubMed ID: 11039452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High FDG uptake on PET is associated with negative cell-to-cell adhesion molecule E-cadherin expression in lung adenocarcinoma.
    Higashi K; Ueda Y; Shimasaki M; Ishigaki Y; Nakamura Y; Oguchi M; Takegami T; Watanabe N
    Ann Nucl Med; 2017 Oct; 31(8):590-595. PubMed ID: 28677069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of 18F-FLT and 18F-FDG uptake on PET with Ki-67 immunohistochemistry in non-small cell lung cancer.
    Yamamoto Y; Nishiyama Y; Ishikawa S; Nakano J; Chang SS; Bandoh S; Kanaji N; Haba R; Kushida Y; Ohkawa M
    Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1610-6. PubMed ID: 17530250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo and in vitro multitracer analyses of P-glycoprotein expression-related multidrug resistance.
    Márián T; Szabó G; Goda K; Nagy H; Szincsák N; Juhász I; Galuska L; Balkay L; Mikecz P; Trón L; Krasznai Z
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1147-54. PubMed ID: 12830325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological correlates of FDG uptake in non-small cell lung cancer.
    de Geus-Oei LF; van Krieken JH; Aliredjo RP; Krabbe PF; Frielink C; Verhagen AF; Boerman OC; Oyen WJ
    Lung Cancer; 2007 Jan; 55(1):79-87. PubMed ID: 17046099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma.
    Higashi K; Ueda Y; Seki H; Yuasa K; Oguchi M; Noguchi T; Taniguchi M; Tonami H; Okimura T; Yamamoto I
    J Nucl Med; 1998 Jun; 39(6):1016-20. PubMed ID: 9627336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Glut-1 and Glut-3 in untreated oral squamous cell carcinoma compared with FDG accumulation in a PET study.
    Tian M; Zhang H; Nakasone Y; Mogi K; Endo K
    Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):5-12. PubMed ID: 14551748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of [(18)F]FDG PET and (201)Tl SPECT in evaluation of pulmonary nodules.
    Higashi K; Ueda Y; Sakuma T; Seki H; Oguchi M; Taniguchi M; Taki S; Tonami H; Katsuda S; Yamamoto I
    J Nucl Med; 2001 Oct; 42(10):1489-96. PubMed ID: 11585862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor fluoro-2-deoxy-D-glucose avidity on positron emission tomographic scan predicts mortality in patients with early-stage pure and mixed bronchioloalveolar carcinoma.
    Raz DJ; Odisho AY; Franc BL; Jablons DM
    J Thorac Cardiovasc Surg; 2006 Nov; 132(5):1189-95. PubMed ID: 17059942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of Glut-1 glucose transporter expression with [(18)F]FDG uptake in non-small cell lung cancer.
    Higashi K; Ueda Y; Sakurai A; Mingwang X; Xu L; Murakami M; Seki H; Oguchi M; Taki S; Nambu Y; Tonami H; Katsuda S; Yamamoto I
    Eur J Nucl Med; 2000 Dec; 27(12):1778-85. PubMed ID: 24578007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. To predict response chemotherapy using technetium-99m tetrofosmin chest images in patients with untreated small cell lung cancer and compare with p-glycoprotein, multidrug resistance related protein-1, and lung resistance-related protein expression.
    Kuo TH; Liu FY; Chuang CY; Wu HS; Wang JJ; Kao A
    Nucl Med Biol; 2003 Aug; 30(6):627-32. PubMed ID: 12900288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microvessel density: correlation with 18F-FDG uptake and prognostic impact in lung adenocarcinomas.
    Guo J; Higashi K; Ueda Y; Oguchi M; Takegami T; Toga H; Sakuma T; Yokota H; Katsuda S; Tonami H; Yamamoto I
    J Nucl Med; 2006 Mar; 47(3):419-25. PubMed ID: 16513610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression.
    Yen TC; See LC; Lai CH; Yah-Huei CW; Ng KK; Ma SY; Lin WJ; Chen JT; Chen WJ; Lai CR; Hsueh S
    J Nucl Med; 2004 Jan; 45(1):22-9. PubMed ID: 14734665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between non-small cell lung cancer FDG uptake at PET, tumor histology, and Ki-67 proliferation index.
    Vesselle H; Salskov A; Turcotte E; Wiens L; Schmidt R; Jordan CD; Vallières E; Wood DE
    J Thorac Oncol; 2008 Sep; 3(9):971-8. PubMed ID: 18758298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro proton magnetic resonance spectroscopic lactate and choline measurements, 18F-FDG uptake, and prognosis in patients with lung adenocarcinoma.
    Guo J; Higashi K; Yokota H; Nagao Y; Ueda Y; Kodama Y; Oguchi M; Taki S; Tonami H; Yamamoto I
    J Nucl Med; 2004 Aug; 45(8):1334-9. PubMed ID: 15299058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET.
    Visser EP; Philippens ME; Kienhorst L; Kaanders JH; Corstens FH; de Geus-Oei LF; Oyen WJ
    J Nucl Med; 2008 Jun; 49(6):892-8. PubMed ID: 18483085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localized form of bronchioloalveolar carcinoma: FDG PET findings.
    Kim BT; Kim Y; Lee KS; Yoon SB; Cheon EM; Kwon OJ; Rhee CH; Han J; Shin MH
    AJR Am J Roentgenol; 1998 Apr; 170(4):935-9. PubMed ID: 9530038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.